BrioHealth announced that it received conditional FDA approval to conduct a clinical evaluation of its ventricular assist device (VAD) in pediatric patients.
Burlington, Massachusetts–based BrioHealth...
Xeltis has gained a European CE mark for aXess, with 12-month pivotal data of the vascular access graft for haemodialysis demonstrating strong and higher...
Corify Care announced that it received FDA clearance for its Acorys imageless, non-invasive cardiac mapping platform.
Madrid-based Corify designed its platform to provide a global,...
AliveCor announced that it received CE mark for its Kardia 12L electrocardiogram (ECG) system.
Mountain View, California-based AliveCor describes it as the world’s first AI-powered,...
ProSomnus announced that it received FDA 510(k) clearance for its RPMO₂ obstructive sleep apnea (OSA) therapy device.
San Francisco–based ProSomnus says its clearance marks the...
Adagio Medical announced that it received FDA investigational device exemption (IDE) to expand its FULCRUM-VT trial.
FULCRUM-VT evaluates the company’s vCLAS cryoablation technology for treating...
Anumana, a leader in cardiovascular AI, announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI algorithm for cardiac amyloidosis (CA) – the...
CorTec GmbH, a pioneer in fully implantable brain-computer interfaces (BCI), announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation...
Allevion Medical has secured the US Food and Drug Administration (FDA) 510(k) clearance for Vantage, a fully disposable and sterile system intended to simplify...